Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011)
Alaunos Therapeutics (TCRT) reported Cost of Revenue of $10.7 million for Q3 2011, up 86.78% on a YoY basis from $5.7 million in Q3 2010, and up 16.9% quarter-over-quarter from $9.1 million in Q2 2011.
Alaunos Therapeutics (TCRT) Cost of Revenue (2009 - 2011) Analysis & Trends
Alaunos Therapeutics has reported Cost of Revenue for 3 years, with the latest figure at $10.7 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 10.67 Mn |
| Sep 30, 2011 | 10.67 Mn |
| Jun 30, 2011 | 9.13 Mn |
| Jun 30, 2011 | 9.13 Mn |
| Sep 30, 2010 | 5.71 Mn |
| Sep 30, 2010 | 5.71 Mn |
| Jun 30, 2010 | 2.22 Mn |
| Jun 30, 2010 | 2.22 Mn |
| Sep 30, 2009 | 1.23 Mn |
| Sep 30, 2009 | 1.23 Mn |